Ghaya Nasr: Advancing Care Standards and Therapeutic Progress at ISTH 2026
Ghaya Nasr, Disease Commercialization Lead at Roche, shared a post on LinkedIn:
“Leaving International Society on Thrombosis and Haemostasis (ISTH) with a full mind. And an even fuller heart.
Science moves us forward.
People give it meaning.
Innovation changes what is possible.
Human connection reminds us why it matters.
This week was about breakthrough science.
It was also about courage. Resilience. Hope. And the privilege of connecting with the people behind every conversation.
What touched me most was witnessing the collective commitment to improving the lives of people living with bleeding disorders.
Across countries. Across disciplines. Across cultures.
I am especially proud of the progress we are making across the Middle East.
Step by step.
Country by country.
Together with healthcare professionals, patient communities and partners, we are bringing innovation closer to patients and helping ensure they can benefit from standards of care that rival those available anywhere in the world.
Progress is measured in science.
Impact is measured in lives.
Grateful for the conversations. The inspiration. And the reminder that behind every innovation is a human story worth changing.
Here for generations. Here for life.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question